Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Wang

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Neoplasia (New York, N.Y.)|April 14, 2006
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivoKeith G Wolter, Steven J Wang, Bradley S Henson, et al.
Oral Oncology|June 1, 2017
Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patientSteven J Wang, Saurabh Asthana, Annemieke van Zante, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 3, 2018
Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal DiseaseKarolina A Plonowska, Madeleine P Strohl, Steven J Wang, et al.
Head & Neck|October 1, 2022
American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinomaCecelia E Schmalbach, Thomas J Ow, Karen Y Choi, et al.
Cancer|February 8, 2017
A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neckBindu V Manyam, Adam A Garsa, Re-I Chin, et al.
JAMA Dermatology|February 28, 2019
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality TherapyLillian Sun, Re-I Chin, Brian Gastman, et al.
The Laryngoscope|March 15, 2018
Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomasLinda X Yin, Gypsyamber D'Souza, William H Westra, et al.
Cancer|February 28, 2017
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancerCarole Fakhry, William H Westra, Steven J Wang, et al.
The Laryngoscope|March 29, 2019
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancerMary Jue Xu, Karolina A Plonowska, Zev R Gurman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck CancerZoya Qureshy, Hua Li, Yan Zeng, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Neoplasia (New York, N.Y.)|April 14, 2006
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivoKeith G Wolter, Steven J Wang, Bradley S Henson, et al.
Oral Oncology|June 1, 2017
Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patientSteven J Wang, Saurabh Asthana, Annemieke van Zante, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 3, 2018
Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal DiseaseKarolina A Plonowska, Madeleine P Strohl, Steven J Wang, et al.
Head & Neck|October 1, 2022
American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinomaCecelia E Schmalbach, Thomas J Ow, Karen Y Choi, et al.
Cancer|February 8, 2017
A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neckBindu V Manyam, Adam A Garsa, Re-I Chin, et al.
JAMA Dermatology|February 28, 2019
Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality TherapyLillian Sun, Re-I Chin, Brian Gastman, et al.
The Laryngoscope|March 15, 2018
Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomasLinda X Yin, Gypsyamber D'Souza, William H Westra, et al.
Cancer|February 28, 2017
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancerCarole Fakhry, William H Westra, Steven J Wang, et al.
The Laryngoscope|March 29, 2019
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancerMary Jue Xu, Karolina A Plonowska, Zev R Gurman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck CancerZoya Qureshy, Hua Li, Yan Zeng, et al.
Pageof 9